The Cancer Research Institute (CRI) assembles a team to participate in the 2019 TD Five Boro Bike Tour on May 5, 2019.
Drs. Jill O'Donnell-Tormey and Vanessa M. Lucey are participating in panel discussions at Cancer Progress.
This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.
Through the Kitchen, supporting CRI Irvington Postdoctoral Fellowship Program, is the only charitable event for which guests are invited to walk “through” the kitchen at The Pool & The Grill in the Seagram Building,
Join us for the 7th Annual Cancer Immunotherapy Month™ in June hosted by the Cancer Research Institute.
On Friday, June 14, 2019, we invite you to wear white for a future immune to cancer, raising awareness of the lifesaving potential of immunotherapy, as part of the 7th Annual Cancer Immunotherapy Month.
In this webinar for patients and caregivers, a cancer veteran and his/her oncologist discuss the importance of communication among patient, caregiver, and doctor throughout immunotherapy treatment.
Register for a free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy from Drs. Tanya Dorff, Roger Lo, Aaron Miller, and Rebecca Shatsky.
Register for a free event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy.
Register for a free, virtual event for patients, caregivers, and advocates to learn about new breakthroughs in cancer immunotherapy.
Dr. Michel Sadelain of Memorial Sloan Kettering highlights a revolutionary new treatment approach—CAR T cell immunotherapy—that he helped pioneer.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
AACR19 highlighted incredible advances in our efforts to leverage cutting-edge science in order to improve medical treatment for cancer patients.
Scientists tackled novel immunotherapy strategies that could potentially enable more patients with more types of cancer to benefit.